key: cord-0828028-yhrajkhu authors: Chong, Chia‐Yin; Yung, Chee‐Fu; Gan, Cherie; Thio, Szu‐Tien; Tan, Natalie Woon‐Hui; Tee, Nancy Wen‐Sim; Lin, Cui; Lin, Raymond Tze‐Pin; Thoon, Koh‐Cheng title: The burden and clinical manifestation of hospitalized influenza among different pediatric age‐groups in the tropics date: 2019-10-13 journal: Influenza Other Respir Viruses DOI: 10.1111/irv.12692 sha: 5e3580584a2340a7db087f4115d14f6782e22a36 doc_id: 828028 cord_uid: yhrajkhu INTRODUCTION: In tropical Singapore, influenza occurs all year‐round. This study of influenza‐confirmed hospitalized pediatric patients compared clinical characteristics and complications by age‐group and differences between influenza A and B. METHODS: This was a retrospective study of pediatric inpatients from January 2013 to December 2014. Patients were grouped into: <6 months, 6 months to <5 years, 5‐ to <10‐year and ≥10 years. Complications were classified into neurologic, pulmonary, and other. We also calculated the incidence of hospitalized influenza cases per 100 000 age‐related population. RESULTS: There were a total of 1272 patients with a median age of 37 months. The highest hospitalization rates were in the <6 months age‐group. Majority (75.2%) had no comorbidity; 25.6% had complications: neurologic 11.9%, pulmonary 9.6%, other 4.1%. Patients with other complications were older, male, and had the highest influenza B rates and the longest length of stay. Influenza A comprised 76.9% of cases and had higher complication rates especially neurologic, compared to influenza B. Influenza B patients were older and were more likely to develop other complications. The 6‐month to <5‐year‐age‐group had the highest complication rate (30.6%), especially neurologic. However, ≥10 years old had the highest other complications, ICU/ high‐dependency admissions and influenza B Victoria rates. CONCLUSIONS: Infants <6 months had the highest hospitalization rates for influenza. The 6‐month to <5‐year‐age‐group had the highest complication rate especially neurologic. Influenza A patients were younger, had higher seizure rates and complications compared to influenza B. cases were defined as upper respiratory tract manifestations and influenza-unrelated illness, for example, urinary tract infection (UTI). High dependency (HD) is a unit that caters for more severely ill patients requiring closer monitoring or non-invasive ventilation without needing ICU admission. Obesity was defined as BMI > 25 kg/m 2 . Immunosuppression was defined as non-malignancy related immunosuppressive therapy, for example, steroids, biological modifying agents. Pneumonia was defined as fever and cough with chest Xray (CXR) changes of lobar/broncho-pneumonia or focal infiltrates. Positive bacterial tests were either culture-positive from any site or positive mycoplasma PCR or serology (particle agglutination IgG antibody ≥320 single titer). C-reactive protein was the result on admission. Criteria for treating influenza with oseltamivir were as follows: age <2 years or any high-risk factor for complicated disease within 3 days of onset, or severe disease based on clinician assessment independent of duration since onset. Statistical analysis was performed using the spss 19.0 statistical software program. Student's t test or one-way ANOVA were used to compare continuous data; chi-square test or Fisher's exact test was used to compare categorical data, using P < .05 as statistical significance. This study was approved by the internal review board for waiver of consent. Incidence of influenza hospitalization was derived using 56.8% market share for admissions in children and calculated as per 100 000 population based on the number of children in that agegroup (information from MOH and Singapore government statistics). There were a total of 1272 influenza-positive patients admitted with a median age of 37 months (IQR 13-76 months); males constituted 56.5%. Majority were positive for influenza by IF (96.5%) compared to PCR (3.5%). The median length of stay (LOS) was 3 days (IQR 2-4 days). C-reactive protein and chest X-ray were performed in 28.8% and 31.1% of patients, respectively. Figure 1 shows the burden of influenza hospitalizations by year, age-groups, and subtypes/lineages (excluding unknown subtypes/lineages). Incidence of hospitalized influenza was highest for <6 months, followed by 6-month to <5-year-age-group and lowest in ≥10-year-age-group. Figure 2 shows the monthly incidence of The 6-month to <5-year-age-group (54.0%) and ≥10-year-agegroup (11.6%) constituted the largest and smallest proportion, respectively. The 5-to <10-year and ≥10-year-age-groups had the highest rates of influenza B, while <6-month-age-group had the highest rates of influenza A. The <6-month-age-group had the influenza-related complication rates but the highest bacterial infection rates and antibiotic usage. The 6-month to <5-year-age-group had the highest seizure rates, cough duration, CRP, and complication rates. The 5-to <10-year-age-group had the highest influenza B Yamagata rates and prior seizure history. The ≥10-year-age-group had the highest rates of comorbidity, other complications, ICU/HD admissions, and mean LOS. Influenza-unrelated illnesses occurred in 33 patients (2.6%), for example, UTI (n = 12), allergic reactions (n = 8), salmonella gastroenteritis (n = 2), cellulitis (n = 2) mesenteric adenitis (n = 2), eye in- Fifty-six (4.4%) cases were admitted ICU or HD. Table 3 lists the type of complications. Neurologic complications were the most frequent (46.5%) followed by pulmonary (37.5%) and other (16.0%). The seven complicated cases with confirmed bacterial coinfection were as follows: two pneumococcal bacteremia, two S pyogenes bacteremia, one each for P aeuginosa pneumonia, Mycoplasma pneumonia, and campylobacter gastroenteritis (admitted for febrile seizure). Overall, oseltamivir (OSV) usage was 2.0%, especially higher in complicated cases (3.6% vs 1.3%, P = .007), ICU/HD admissions (19.6% vs 1.2%, P < .001), underlying comorbidity (4.5% vs 1.3%, P = .002), cardiac disease (10.7% vs 1.6%, P < .001), and malignancy (30% vs 1.7%, P = .001). In contrast, any antibiotic usage was 28.4%. Comparing patients with other complications against neurologic and pulmonary complications, they had the highest ICU/HD admissions (34.6% vs 12.6%, 10.7%, respectively, P < .001), highest influenza B rates (36.5% vs 10.6%, 18.9%, respectively, P < .001) and oldest age (mean 90.3 vs 50.6, 42.1 months respectively, P < .001). Pulmonary complications compared to neurologic and other complications had highest ILI rates (91.8% vs 68.2%, 76.9% respectively, P < .001), longest cough duration (6.5 days vs 3.2, 3.7 days, respectively, P = .010). LOS was not significantly different between the type of complications. The mortality rate in our cohort was 0.2%. The three deaths were as follows: Acute necrotizing encephalitis, invasive pneumococcal disease, decompensated liver failure in a biliary atresia patient post-Kasai procedure. One cerebral palsy patient with no prior seizures developed sequelae of epilepsy. The main findings from our study were that the highest burden of influenza hospitalizations was in the <6-month-age-group, followed by the 6-month to <5-year-age-group. Majority (75.2%) of pediatric inpatients had no comorbidity and 25.6% had complications: neurologic 11.9%, pulmonary 9.6%, and other 4.1%. The 6-month to <5-year-age-group suffered the highest complication rate (30.6%). Influenza A patients were younger, had higher seizure rates and complications compared to influenza B. In our study, the highest hospitalization rate occurred in the <6-month-age-group. This is similar to Hong Kong but different from temperate countries where the highest rates occurred in the 6-to 23-month-age-group. [10] [11] [12] Patients who were ≤6 weeks or <3 months old were likely admitted for neonatal or infantile pyrexia workup, this can explain the high UTI rates and antibiotic usage in this age-group. At the average rate of 881.68 per 10 5 population for <6 months old, it is higher than temperate countries. 3, 13 This could be due to all year-round influenza with bimodal peaks, similar to Malaysia. 14 Studies have shown that maternal influenza vaccination can prevent influenza in infants; therefore, pregnant women should receive influenza vaccination to protect their infants. 15, 16 The age-group 6 month to <5 years was the largest cohort (54%) with the second-highest hospitalization rate and the highest complication rate (30.6%) especially neurologic, similar to another study. 17 In other studies, the age-group 6-35 months or the lowest agegroups had the highest incidence of complications. 11, 18, 19 However, the ≥10-year-old-age-group had the highest other complications, ICU/high-dependency admissions, and influenza B Victoria rates. This is unlike other studies which had higher ICU admissions in the youngest age-groups <12 months. 20 Abbreviation: SD, standard deviation. especially pneumonia and asthma exacerbation. 11, 16 Infants <6 months had the highest hospitalization rates for influenza. The 6-month to <5-year-age-group had the highest complication rate especially neurologic. Influenza A patients were younger, had higher seizure rates and complications compared to influenza B. We thank Yixiang Ng, Senior Statistician, Epidemiology & Disease Control Division, Ministry of Health, Singapore, for providing data on KKH market share and pediatric hospitalizations by age-group. Chia-Yin Chong https://orcid.org/0000-0003-3919-3324 Influenza surveillance in Singapore 1972-86 Characterization of Influenza activity based on virological surveillance of Influenza-like illness in tropical Singapore Influenza-associated hospitalizations Risk factors for complicated influenza A (H1N1) 2009 disease in children Recommendations for prevention and control of influenza in children Identification of children at risk of influenza-related complications in primary and ambulatory care: a systematic review and meta-analysis World Health Organization. WHO information for molecular diagnosis of influenza virus -update. Publication date Publication date Differentiation of influenza B virus lineages Yamagata and Victoria by real-time PCR Virologically confirmed population-based burden of hospitalization caused by influenza A and B among children in Hong Kong Incidence, complications, and risk factors for prolonged stay in children hospitalized with community-acquired influenza Epidemiology, complications and costs of hospitalization in children with laboratory-confirmed influenza infection Incidence of laboratory-confirmed influenza disease among infants under 6 months of age: a systematic review Comparative global epidemiology of influenza, respiratory syncytial and parainfluenza viruses Effectiveness of maternal influenza immunization in mothers and infants Influenza in infants born to women vaccinated during pregnancy Neurologic complications in children hospitalized with influenza: characteristics, incidence and risk factors The burden of influenza in young children A study of influenza and influenza-related complications among children in a large US health insurance plan database Influenza and the rates of hospitalization for respiratory disease among infants and young children Hospitalization for influenza A versus B A review of the value of quadrivalent influenza vaccines and their potential contribution to influenza control Changes in trends and impact of testing for influenza in infants with fever <90 days of age The spectrum and burden of influenza-associated neurological disease in children: combined encephalitis and influenza sentinel site surveillance from Australia Influenza vaccination in children with neurologic or neurodevelopmental disorders Epidemiological and virological characteristics of influenza B: results of the Global Influenza B Study. Influenza Other Respir Viruses Population-based pediatric hospitalization burden of lineage-specific influenza B in Hong Kong Differing epidemiological dynamics of influenza B virus lineages in Guangzhou, southern China Increasing similarity in the dynamics of influenza in two adjacent subtropical Chinese cities following the relaxation of border restrictions Epidemiological and evolutionary dynamics of influenza B viruses in Malaysia 2012-2014 The burden and clinical manifestation of hospitalized influenza among different pediatric age-groups in the tropics